Adriana Estrada, PhD, University of Colorado Anschutz Medical Campus (IMAGE)

University of Colorado Anschutz

Adriana Estrada, PhD, University of Colorado Anschutz Medical Campus

Caption

Adriana Estrada, PhD, and University of Colorado Cancer Center colleagues report promising preclinical results for tarloxitinib against EGFR exon 20 insertion lung cancer.

Credit

University of Colorado Cancer Center

Usage Restrictions

with attribution

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.